EDMONTON, AB – Ceapro Inc. has officially opened its new 30,000-square-foot bioprocessing extraction and manufacturing facility in Edmonton, AB.
The facility launch was highlighted by a special ceremony attended by Alberta Premier Rachel Notley, as well as other dignitaries, corporate partners and members of the press. At the launch, Gilles Gagnon, company president and CEO called the “bio-processing extraction facility is a notable step forward in the company’s corporate development.
The facility, which will enable the development of new bio-products and technologies, was built with support from Alberta Innovates Bio Solutions, the Agrivalue Processing Business Incubator, the National Research Council, Agriculture Financial Services Corp, Agriculture and Agri-Food Canada and Symrise AG.
The company— which employs approximately 30 people — specializes in taking raw materials, such as oats, and turning them into active ingredients in healthcare and cosmetic products.
The company’s two main products are beta glucan and avenanthramides, which are both extracted from oats. Beta glucan provides relief from itching and reduces inflammation, while avenanthramides are an anti-irritant that accelerate tissue healing.
“As we transfer our manufacturing to our new facility, we will seamlessly and without interruption continue to develop our pipeline and execute our projects rigorously toward market expansion into the profitable nutraceutical and pharmaceutical sectors,” concluded Gagnon.
In addition to current extraction fractionation process technologies, Ceapro’s new bio-processing GMP facility includes an expanded production area specifically designed to house a commercial and demonstration scale PGX skid and an ethanol recycling system which will make Ceapro a “greener” company. The company has also in-licensed its proprietary PGX enabling technology for worldwide use in all industries and all applications and is developing PGX at the commercial scale level.